

Overview
Respiratory syncytial virus (RSV) is a common respiratory virus transmitted through respiratory droplets. While RSV infection causes mild cold-like symptoms for most adults, infants and at-risk individuals can develop serious respiratory symptoms such as bronchiolitis and pneumonia.
Current treatments for RSV in infants are supportive, and RSV management focuses primarily on prevention through immunisation. New and emerging options for RSV prevention such as vaccines and monoclonal antibodies are becoming available; they work by providing passive immunity to infants. Understanding the mechanism of RSV immunisation is crucial for grasping its protection characteristics, including duration and consistency of protection, as well as its potential benefits and limitations.
This e-learning module provides an overview of the various clinical presentations of RSV infection in infants, the burden of RSV in infants, and current strategies available for RSV prevention, plus their real-world evidence.
At the end of this learning module, participants should be able to: